Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ConsenSys is a leading blockchain technology company that primarily develops infrastructure and applications for the Ethereum ecosystem. While its core business focuses on Web3 tools like MetaMask and Infura, the company established ConsenSys Health (now rebranded as Lydion) to apply decentralized technologies to the healthcare and life sciences sectors. This division focuses on creating secure, privacy-preserving data sharing networks and federated machine learning platforms to accelerate clinical trials and improve health data interoperability. By leveraging blockchain and confidential computing, ConsenSys aims to solve complex data silos and compliance challenges within the global healthcare industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ConsenSys.